AMR Sept Banner v2

ASM Attends UN General Assembly

ASM President, Susan Sharp, Ph.D., joined global leaders at the United Nations General Assembly in New York today in a historical meeting to focus on the commitment to fight AMR.
Read

UN General Assembly Focuses on AMR

Leaders at the UN General Assembly draft a plan for coordinated, cross-cutting efforts to improve the current state of AMR.
Read

Superbugs are a 'Fundamental Threat'

If antibiotics were telephones, we would still be calling each other using clunky rotary dials and copper lines," Stefano Bertuzzi, CEO of ASM, told NBC News.
Read
Become a member today!
JOIN ASM
Submit Abstracts for Biothreats 2017
SUBMIT
Antibacterial Development Conference
REGISTER

Dear Colleague:

On July 15, Congress voted to override President Bush’s veto of H.R. 6331, The Medicare Improvements for Patients and Providers Act of 2008, enabling the legislation to become law. The legislation 1) repeals the authority of the Centers for Medicare & Medicaid Services (CMS) to conduct a Medicare Competitive BiddingDemonstration Projectfor Clinical Laboratory Services and 2) extends a moratorium that will allow independent laboratories to continue billing hospitals for the technical component of physician pathology services furnished to hospital patients.

The ASM Public and Scientific Affairs Board has been tracking the implementation of the clinical laboratory demonstration program and alerted its clinical members throughout the various phases of the project, including an announcement of the first demonstration site (San Diego, CA) last fall. PSAB has sent legislative alerts and updates to encourage ASM members to ask their Congressional members to support legislation to repeal the competitive bidding demonstration program. ASM staff joined other organizations in meetings with Congressional staff to inform and educate Congress about the reasons to repeal the demonstration program.

The ASM also joined other professional societies and laboratory organizations in support of a legal case involving three Southern California laboratories against the U.S. Department of Health and Human Services (HHS) regarding the potential impact of the demonstration project on the Medicare population and clinical laboratories; the case resulted in a temporary injunction placed on HHS prohibiting CMS from announcing laboratory bid “winners” and from further carrying out the demonstration in the San Diego area. However, Congressional action was necessary to completely repeal CMS’s statutory authority for fully implementing the demonstration project. Subsection 145 (a) of H.R. 6331, enacted on July 15, repeals the Medicare Competitive Bidding Demonstration Project for Clinical Laboratory Services in San Diego and any other future location by striking subsection (e) of section 1847 of the Social Security Act (42 U.S.C. 1395w-3). This action is effective immediately.

We wish to thank ASM members who took the time to write their Congressional delegation in support of the repeal legislation.

Sincerely,

Vickie Baselski, Ph.D., Chair, PSAB Committee on Professional Affairs
Susan Sharp, Ph.D., Chair, PSAB Committee on Laboratory Practices
Ruth Berkelman, M.D., Chair, Public and Scientific Affairs Board

 

TPL_asm2013_SEARCH

8172